User profiles for Peter E. Huber

peter huber or peter e huber

German Cancer Research Center dkfz /University Hospital Heidelberg
Verified email at dkfz.de
Cited by 21251

Brain tumour cells interconnect to a functional and resistant network

…, S Weiss, H Liu, S Heiland, M Platten, PE Huber… - Nature, 2015 - nature.com
Astrocytic brain tumours, including glioblastomas, are incurable neoplasms characterized
by diffusely infiltrative growth. Here we show that many tumour cells in astrocytomas extend …

[PDF][PDF] Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy

F Klug, H Prakash, PE Huber, T Seibel, N Bender… - Cancer cell, 2013 - cell.com
Inefficient T cell migration is a major limitation of cancer immunotherapy. Targeted activation
of the tumor microenvironment may overcome this barrier. We demonstrate that …

MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study

K Hynynen, O Pomeroy, DN Smith, PE Huber… - Radiology, 2001 - pubs.rsna.org
PURPOSE: To test the feasibility of noninvasive magnetic resonance (MR) imaging–guided
focused ultrasound surgery (FUS) of benign fibroadenomas in the breast. MATERIALS AND …

[PDF][PDF] Endostatin's antiangiogenic signaling network

…, J Debus, W Ansorge, J Folkman, L Hlatky, PE Huber - Molecular cell, 2004 - cell.com
It is here demonstrated that the set of gene expressions underlying the angiogenic balance
in tissues can be molecularly reset en masse by a single protein. Using genome-wide …

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis

…, HJ Gröne, KE Lipson, PE Huber - The Journal of …, 2005 - rupress.org
Pulmonary fibrosis is the consequence of a variety of diseases with no satisfying treatment
option. Therapy-induced fibrosis also limits the efficacy of chemotherapy and radiotherapy in …

A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery

PE Huber, JW Jenne, R Rastert, I Simiantonakis… - Cancer research, 2001 - AACR
An ideal vision of modern medicine includes tumor surgery with the human body remaining
completely intact. A noninvasive therapy could avoid infections and scar formation; it would …

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

T Lammers, V Subr, K Ulbrich, P Peschke, PE Huber… - Biomaterials, 2009 - Elsevier
Copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) are prototypic and well-characterized
polymeric drug carriers that have been broadly implemented in the delivery of …

Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype

…, R Erber, S Short, L Hlatky, P Vajkoczy, PE Huber… - Cancer research, 2009 - AACR
Tumor dormancy has important implications for early detection and treatment of cancer. Lack
of experimental models and limited clinical accessibility constitute major obstacles to the …

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

…, RA Reisfeld, J Debus, AG Niethammer, PE Huber - Clinical cancer …, 2005 - AACR
The involvement of α v β 3 and α v β 5 integrins in angiogenesis and the use of integrin
antagonists as effective antiangiogenic agents are documented. Radiotherapy is an important …

Transcriptional network governing the angiogenic switch in human pancreatic cancer

…, H Friess, J Folkman, PE Huber - Proceedings of the …, 2007 - National Acad Sciences
A shift of the angiogenic balance to the proangiogenic state, termed the “angiogenic switch,”
is a hallmark of cancer progression. Here we devise a strategy for identifying genetic …